Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 29 January 2009, doi:10.1136/bmj.b280
Cite this as: BMJ 2009;338:b280
Dr Moises Selman is a world expert in the complex field of interstitial lung diseases. Currently director of research at the National Institute of Respiratory Diseases in Mexico, Dr Selman has received many accolades for his contribution in pulmonary fibrosis and has served in committees and boards as a leader in this area.
He has participated in the transcriptional research of these diseases and his work is considered to be groundbreaking and clinically important.
Dr Selman is a member of many international and prestigious organisations and his international reputation is evident from the numerous invitations he has received to influential committees.
He was a member of the board of directors of the American Thoracic Society, governor for Mexico for the American College of Chest Physicians, and president of the Mexican Society of Pulmonology.
In 1993 he received the prestigious John Simon Guggenheim Memorial Foundation Fellowship, and he has also won many awards for his research.
Dr Selman made a seminal contribution in idiopathic pulmonary fibrosis by proposing a new hypothesis for the pathogenesis of this devastating disorder. His work has led to a shift in understanding of the disease.
Dr Selman has also been praised for the fact that his scientific contributions were made in Mexico, in conditions often considered to be close to those of a developing country.
Cite this as: BMJ 2009;338:b280
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?